Home Business Novavax COVID-19 vaccine proves 90% effective and protects against variants, company says

Novavax COVID-19 vaccine proves 90% effective and protects against variants, company says

by staff

In May, vaccines alliance Gavi announced it had signed an agreement to buy 350 million doses of Novavax’s vaccine, with deliveries estimated to begin in the third quarter. COVAX, the global initiative to provide vaccines to countries, is facing a critical shortage of vaccines after its biggest supplier in India suspended exports until the end of the year,

Related Articles

Leave a Comment